Bio-Path Holdings, Inc.
BPTH
$0.10
-$0.02-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -55.88% | -10.16% | 6.74% | 33.84% | -2.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.16% | -12.29% | -13.45% | -19.60% | -28.38% |
| Operating Income | -50.16% | 12.29% | 13.45% | 19.60% | 28.38% |
| Income Before Tax | -145.96% | 9.66% | 18.36% | 33.89% | 55.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -145.96% | 9.66% | 18.36% | 33.89% | 55.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.96% | 9.66% | 18.36% | 33.89% | 55.86% |
| EBIT | -50.16% | 12.29% | 13.45% | 19.60% | 28.38% |
| EBITDA | -50.07% | 11.82% | 13.62% | 19.24% | 28.15% |
| EPS Basic | 52.28% | 91.72% | 88.40% | 88.98% | 89.10% |
| Normalized Basic EPS | 52.28% | 91.72% | 88.40% | 88.98% | 89.10% |
| EPS Diluted | 52.28% | 91.72% | 88.40% | 88.98% | 89.10% |
| Normalized Diluted EPS | 52.28% | 91.72% | 88.40% | 88.98% | 89.10% |
| Average Basic Shares Outstanding | 415.38% | 991.50% | 603.92% | 499.80% | 305.03% |
| Average Diluted Shares Outstanding | 415.38% | 991.50% | 603.92% | 499.80% | 305.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |